valyl-prolyl-glycyl-valyl-glycine: a synthetic elastin peptide; do not confuse with polymeric VPGVG [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 6452594 |
SCHEMBL ID | 1371152 |
MeSH ID | M0249925 |
Synonym |
---|
vpgvg |
val-pro-gly-val-gly |
glycine, n-(n-(n-(1-l-valyl-l-prolyl)glycyl)-l-valyl)- |
valyl-prolyl-glycyl-valyl-glycine |
52231-42-2 |
n-(n-(n-(1-l-valyl-l-prolyl)glycyl)-l-valyl)glycine |
SCHEMBL1371152 |
DTXSID90200279 |
val-pro-gly-val-gly-oh |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.54) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |